@article{c10e044b1f6843d49bc446c9a7b53aab,
title = "Making the case for causality: What role do lung microbiota play in idiopathic pulmonary fibrosis?: European Respiratory Journal",
keywords = "antibiotic agent, azithromycin, corticosteroid, cotrimoxazole, macrolide, monoclonal antibody, probiotic agent, all cause mortality, bacterial load, bronchiectasis, bronchoscopy, computer assisted tomography, disease severity, fibrosing alveolitis, human, lung microbiota, microbiome, microflora, nonhuman, priority journal, prognosis, Review, Streptococcus pneumoniae, disease exacerbation, lung, Disease Progression, Humans, Idiopathic Pulmonary Fibrosis, Lung, Microbiota",
author = "R.P. Dickson and S. Harari and M. Kolb",
note = "Cited By :2 Export Date: 1 March 2021 CODEN: ERJOE Correspondence Address: Dickson, R.P.; Pulmonary and Critical Care Medicine, 1150 W. Medical Center Dr, United States; email: rodickso@med.umich.edu",
year = "2020",
doi = "10.1183/13993003.00318-2020",
language = "English",
volume = "55",
journal = "Eur. Respir. J.",
issn = "0903-1936",
publisher = "European Respiratory Society",
number = "4",
}